SB 242 084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

[1]  R. Roth,et al.  Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.

[2]  E. Azmitia,et al.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat , 1978, The Journal of comparative neurology.

[3]  O. Phillipson.  Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the rat , 1979, The Journal of comparative neurology.

[4]  A. Grace,et al.  Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence. , 1980, Science.

[5]  B. Cox,et al.  Characterisation of Inhibitory 5‐Hydroxytryptamine Receptors That Modulate Dopamine Release in the Striatum , 1981, Journal of neurochemistry.

[6]  Rex Y. Wang.  Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization , 1981, Brain Research Reviews.

[7]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[8]  A. Grace,et al.  The control of firing pattern in nigral dopamine neurons: burst firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[10]  C. D. Stern,et al.  Handbook of Chemical Neuroanatomy Methods in Chemical Neuroanatomy. Edited by A. Bjorklund and T. Hokfelt. Elsevier, Amsterdam, 1983. Cloth bound, 548 pp. UK £140. (Volume 1 in the series). , 1986, Neurochemistry International.

[11]  L. Cervo,et al.  Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test , 1987, Neuropharmacology.

[12]  R. Glennon,et al.  Central serotonin receptors as targets for drug research. , 1987, Journal of medicinal chemistry.

[13]  A. Beaudet,et al.  Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons , 1987, Brain Research.

[14]  F. Gonon.  Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry , 1988, Neuroscience.

[15]  L. Cervo,et al.  Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens , 1988, The Journal of pharmacy and pharmacology.

[16]  G. Kennett,et al.  Evidence that mCPP may have behavioural effects mediated by central 5‐HT1C receptors , 1988, British journal of pharmacology.

[17]  T. Jessell,et al.  5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Bunney,et al.  Ionic Composition of Microdialysis Perfusing Solution Alters the Pharmacological Responsiveness and Basal Outflow of Striatal Dopamine , 1989, Journal of neurochemistry.

[19]  W. Soudijn,et al.  The concept of selectivity in 5-HT receptor research. , 1990, European journal of pharmacology.

[20]  L. Cervo,et al.  The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test. , 1990, European journal of pharmacology.

[21]  L. Chiodo,et al.  Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. , 1990, The Journal of pharmacology and experimental therapeutics.

[22]  J. Palacios,et al.  The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution , 1990, Neuroscience.

[23]  R. Roth,et al.  Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  B. Bunney,et al.  Mechanisms of action of atypical antipsychotic drugs Implications for novel therapeutic strategies for schizophrenia , 1991, Schizophrenia Research.

[25]  M. Galloway,et al.  Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. , 1991, European journal of pharmacology.

[26]  A. Mele,et al.  Striatal extracellular dopamine in conscious vs. anesthetized rats: effects of chloral hydrate anesthetic on responses to drugs of different classes , 1992, Brain Research.

[27]  E. sanders-Bush,et al.  5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. , 1993, Molecular pharmacology.

[28]  L. Chiodo,et al.  Ascending afferent regulation of rat midbrain dopamine neurons , 1993, Brain Research Bulletin.

[29]  W. Haefely,et al.  Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. , 1993, European journal of pharmacology.

[30]  M. Pranzatelli,et al.  Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists. , 1993, European journal of pharmacology.

[31]  A. Carlsson,et al.  Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo. , 1994, European journal of pharmacology.

[32]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[33]  E. Esposito,et al.  Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. , 1994, The Journal of pharmacology and experimental therapeutics.

[34]  M. Pompeiano,et al.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.

[35]  U. Spampinato,et al.  Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat , 1995, Neuropharmacology.

[36]  R. Eglen,et al.  The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors , 1995, British journal of pharmacology.

[37]  M. Staufenbiel,et al.  Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera , 1995, Neuropharmacology.

[38]  R. Bruton,et al.  Ability of 5‐HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo , 1996, British journal of pharmacology.

[39]  V. Hillegaart,et al.  Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat , 1996, Neuropharmacology.

[40]  M. Bös,et al.  5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats , 1996, European Neuropsychopharmacology.

[41]  I. Forbes,et al.  In vitro and in vivo profile of SB 206553, a potent 5‐HT2C/5‐HT2B receptor antagonist with anxiolytic‐like properties , 1996, British journal of pharmacology.

[42]  D. Dorsa,et al.  Colocalization of serotonin receptor subtypes 5‐HT2A, 5‐HT2C, and 5‐HT6 with neuropeptides in rat striatum , 1996, The Journal of comparative neurology.

[43]  K. Uryu,et al.  Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats , 1997, The Journal of comparative neurology.

[44]  M. Geffard,et al.  Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra , 1997, Neuroscience.

[45]  A. Brown,et al.  SB 242084, a Selective and Brain Penetrant 5-HT2C Receptor Antagonist , 1997, Neuropharmacology.

[46]  T. Blackburn,et al.  Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system , 1997, Neuroscience.

[47]  M. Millan,et al.  Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo , 1998, Neuropharmacology.

[48]  E. Esposito,et al.  Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens , 1998, Neuropharmacology.

[49]  A. Sleight,et al.  5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. , 1998, The Journal of pharmacology and experimental therapeutics.